FDA Inspection 1117218 — Anna (nmi) Kryzhanivska, MD
The FDA completed an inspection of Anna (nmi) Kryzhanivska, MD on January 24, 2020 in Ivano-Frankivsk. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 24, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Ivano-Frankivsk (Ukraine)
Additional Details
Clinical Investigator (CI)